公开(公告)号：US20240181002A1

公开(公告)日：2024-06-06

申请号：US18515599

申请日：2023-11-21

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyun Woo JEONG ,  Jinoh CHUNG ,  Wanki KIM ,  Jong Hwa ROH

IPC: A61K38/16 ,  A61P3/04

CPC classification number: A61K38/168 ,  A61P3/04 ,  A61K2236/19 ,  A61K2236/333 ,  A61K2236/37

Abstract: The present disclosure relates to a composition for anti-obesity including a green tea peptide composition. Specifically, the green tea peptide composition according to the one aspect of the present disclosure exhibits anti-obesity efficacy through excellent lipid metabolism activation and can be applied to various health functional food compositions and pharmaceutical compositions.

公开(公告)号：US20230095813A1

公开(公告)日：2023-03-30

申请号：US17935949

申请日：2022-09-28

Applicant: AMOREPACIFIC CORPORATION

Inventor： Changyong MOON ,  Su Hwan KIM ,  Jihae LEE ,  Kyoungmi JUNG ,  Wonkyung CHO ,  Wanki KIM ,  Jong Hwa ROH ,  Chan WOONG PARK

IPC: A61K31/197 ,  A61K31/198 ,  A61K31/455 ,  A61P25/00 ,  A61K9/20 ,  A61K9/48 ,  A61K9/14 ,  A61K9/16 ,  A61K9/00 ,  A23L33/15 ,  A23L33/175

Abstract: The present disclosure relates to a composition for improving sleep quality, including γ-aminobutyric acid (GABA) or a salt, hydrate or solvate thereof; and at least one of arginine, niacin, and salts, hydrates and solvates thereof. The composition for improving sleep quality may improve the sleep quality by increasing melatonin secretion. In addition, in another aspect, the present disclosure provides a composition for alleviating stress, including γ-aminobutyric acid (GABA) or a salt, hydrate or solvate thereof; and at least one of arginine, niacin, and salts, hydrates and solvates thereof.

公开(公告)号：US20250120993A1

公开(公告)日：2025-04-17

申请号：US18883178

申请日：2024-09-12

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyun Woo JEONG ,  Wanki KIM ,  Jong Hwa ROH

IPC: A61K31/7048 ,  A61K31/353 ,  A61P3/08

Abstract: A method for controlling blood sugar, including administering an effective amount of Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) to a subject in need thereof is disclosed. In an aspect, a composition including a complex component of Gallocatechin Gallate and Isoquercitrin can effectively inhibit gluconeogenesis in liver cells and effectively improve transport of glucose in differentiated fat cells and liver cells, thereby exhibiting excellent blood sugar control efficacy.

公开(公告)号：US20240226223A1

公开(公告)日：2024-07-11

申请号：US18536404

申请日：2023-12-12

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyun Woo JEONG ,  Jinoh CHUNG ,  Wanki KIM ,  Jong Hwa ROH

IPC: A61K36/82 ,  A61K38/16 ,  A61P21/00

CPC classification number: A61K36/82 ,  A61K38/168 ,  A61P21/00 ,  A61K2236/19 ,  A61K2236/331 ,  A61K2236/333

Abstract: The present disclosure relates to a composition for preventing, improving, or treating muscle loss comprising a green tea peptide composition. Specifically, the green tea peptide composition according to the present disclosure may exhibit an efficacy in preventing, improving, or treating muscle loss through the excellent effects of increasing protein synthesis in muscle cells and inhibiting protein degradation in the muscle cells, and thus may be applied in various health functional food compositions and pharmaceutical compositions.

公开(公告)号：US20230381262A1

公开(公告)日：2023-11-30

申请号：US18325484

申请日：2023-05-30

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyun Woo JEONG ,  Jinoh CHUNG ,  Wanki KIM ,  Jong Hwa ROH

IPC: A61K36/82 ,  A61P29/00 ,  A23L33/105 ,  A23L2/52 ,  A23L33/00

CPC classification number: A61K36/82 ,  A61P29/00 ,  A23L33/105 ,  A23L2/52 ,  A23L33/40

Abstract: A method for reducing absorption of a microplastic in a body, including administering a composition including an effective amount of a green tea extract to a subject in need thereof is disclosed in the specification. One aspect of the present disclosure is the composition may be a food composition or a pharmaceutical composition.

公开(公告)号：US20240390320A1

公开(公告)日：2024-11-28

申请号：US18663736

申请日：2024-05-14

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyun Woo JEONG ,  Wanki KIM ,  Jong Hwa ROH

IPC: A61K31/353 ,  A61K31/7048 ,  A61P3/04

Abstract: Disclosed herein is a method for inhibiting lipogenesis; inhibiting fat accumulation; promoting fat breakdown; reducing body fat; and/or preventing, improving or treating obesity or metabolic diseases. In one aspect, Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) of the present invention have excellent lipid metabolism control effects, can increase mitochondria in adipocytes, and promote the production of brown fat. Therefore, in one aspect, the present invention can provide a method for preventing, improving, or treating obesity or metabolic diseases.

公开(公告)号：US20230372417A1

公开(公告)日：2023-11-23

申请号：US18313465

申请日：2023-05-08

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyun Woo JEONG ,  Donghyun CHO ,  Wanki KIM ,  Jong Hwa ROH

IPC: A61K35/747 ,  A23L33/135 ,  A61P1/16

CPC classification number: A61K35/747 ,  A23L33/135 ,  A61P1/16 ,  A23Y2220/67

Abstract: A method for improving hepatic function, including administering an effective amount of a composition including a green tea-derived Lactiplantibacillus plantarum strain; a culture of the strain; a lysate of the strain; an extract of the strain; an extract of the culture; or an extract of the lysate to a subject in need thereof is disclosed in the specification.

公开(公告)号：US20220218778A1

公开(公告)日：2022-07-14

申请号：US17570765

申请日：2022-01-07

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyun Woo JEONG ,  Si Young CHO ,  Yong Deog HONG ,  Wanki KIM ,  Miyoung PARK

IPC: A61K36/82 ,  A61K31/352 ,  A61K9/20 ,  A61K9/16 ,  A61K9/00 ,  A61P3/04

Abstract: The present disclosure relates to a composition for reducing body fat, which contains a green tea extract containing 4 wt % or more of gallocatechin gallate based on the total weight of the extract as an active ingredient, and a method for preparing the same. The composition according to the present disclosure provides a superior effect of reducing body fat as the green tea extract containing gallocatechin gallate is contained as an active ingredient. Accordingly, it can provide substances effective for treating obesity through various researches.

公开(公告)号：US20210298339A1

公开(公告)日：2021-09-30

申请号：US17217809

申请日：2021-03-30

Applicant: AMOREPACIFIC CORPORATION

Inventor： Su Hwan KIM ,  Sangyoul NA ,  Hyun Woo JEONG ,  Wanki KIM ,  Jisung KIM ,  Chan Woong PARK

IPC: A23L33/105 ,  A23L33/21 ,  A23L29/269 ,  A23D9/007

Abstract: The present disclosure relates to an emulsion composition containing ginseng seed oil and ginseng berry extract, wherein the composition is a single phase. Whereas the existing composition containing a water-soluble ingredient as a main ingredient has the problem that, when ginseng seed oil is added, formulation stability is decreased as the ginseng seed oil is separated from the water-soluble ingredient, the emulsion composition according to the present disclosure exhibits superior stability because the ginseng seed oil is uniformly mixed with the water-soluble ingredient and separation of the ginseng seed oil from the water-soluble ingredient does not occur fora long period of time.

公开(公告)号：US20250120992A1

公开(公告)日：2025-04-17

申请号：US18823345

申请日：2024-09-03

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyun Woo JEONG ,  Wanki KIM ,  Jong Hwa ROH

IPC: A61K31/7048 ,  A61K31/353 ,  A61P1/16

Abstract: This specification discloses a method for improving liver health, including administering an effective amount of Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) to a subject in need thereof. In an aspect, a composition including a complex component of Gallocatechin Gallate and Isoquercitrin effectively reduces oxidative stress and chronic inflammatory reaction that occurs during accumulation of lipids in liver tissue, thereby making it possible to enhance liver health and prevent, improve, or treat various liver diseases such as hepatitis, cirrhosis, and liver cancer.